Onyx Equities LLC and Machine Investment Group’s acquisition of the 1.7 million-square-foot former Merck headquarters last year is one of the largest New Jersey office and life sciences ...

Merck’s Life Science segment is expected to be the largest contributor to the group’s EBITDA, increasing its group contribution from 40% in 2024 to 51% over the next five years.

We believe a narrow moat surrounds Merck KGaA’s diversified business of life sciences, electronics, and biopharmaceuticals. While Merck’s acquisition activities have cut into its economic ...